High-density lipoprotein and the risk of recurrent venous thromboembolism
Eichinger, S., Pecheniuk, N. M., Hron, G., Deguchi, H., Schemper, M., Kyrle, P. A., & Griffin, J. H. (2007) High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation, 115(12), pp. 1609-1614.
BACKGROUND - High-density lipoprotein (HDL) protects against arterial atherothrombosis, but it is unknown whether it protects against recurrent venous thromboembolism. METHODS AND RESULTS - We studied 772 patients after a first spontaneous venous thromboembolism (average follow-up 48 months) and recorded the end point of symptomatic recurrent venous thromboembolism, which developed in 100 of the 772 patients. The relationship between plasma lipoprotein parameters and recurrence was evaluated. Plasma apolipoproteins AI and B were measured by immunoassays for all subjects. Compared with those without recurrence, patients with recurrence had lower mean (±SD) levels of apolipoprotein AI (1.12±0.22 versus 1.23±0.27 mg/mL, P<0.001) but similar apolipoprotein B levels. The relative risk of recurrence was 0.87 (95% CI, 0.80 to 0.94) for each increase of 0.1 mg/mL in plasma apolipoprotein AI. Compared with patients with apolipoprotein AI levels in the lowest tertile (<1.07 mg/mL), the relative risk of recurrence was 0.46 (95% CI, 0.27 to 0.77) for the highest-tertile patients (apolipoprotein AI >1.30 mg/mL) and 0.78 (95% CI, 0.50 to 1.22) for midtertile patients (apolipoprotein AI of 1.07 to 1.30 mg/mL). Using nuclear magnetic resonance, we determined the levels of 10 major lipoprotein subclasses and HDL cholesterol for 71 patients with recurrence and 142 matched patients without recurrence. We found a strong trend for association between recurrence and low levels of HDL particles and HDL cholesterol. CONCLUSIONS - Patients with high levels of apolipoprotein AI and HDL have a decreased risk of recurrent venous thromboembolism. © 2007 American Heart Association, Inc.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Lipoproteins, Risk factors, Thrombosis, Veins, apolipoprotein A1, apolipoprotein B, high density lipoprotein, high density lipoprotein cholesterol, adult, article, controlled study, disease association, female, follow up, human, immunoassay, lipoprotein blood level, major clinical study, male, nuclear magnetic resonance, priority journal, recurrent disease, venous thromboembolism, Aged, Antibodies, Antiphospholipid, Apolipoprotein A-I, Apolipoproteins B, Austria, Cholesterol, HDL, Cohort Studies, Disease Susceptibility, Follow-Up Studies, Humans, Kaplan-Meiers Estimate, Lipoproteins, HDL, Middle Aged, Nuclear Magnetic Resonance, Biomolecular, Prospective Studies, Pulmonary Embolism, Recurrence, Risk, Sex Factors, Thrombophilia, Venous Thrombosis|
|Divisions:||Current > Institutes > Institute of Health and Biomedical Innovation|
|Copyright Owner:||Lippincott, Williams & Wilkins|
|Deposited On:||22 Jul 2011 06:53|
|Last Modified:||25 Jul 2011 03:51|
Repository Staff Only: item control page